These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2649019)

  • 1. [Differentiated thyroid carcinoma of follicular origin: new data in 1988].
    De Micco C
    Arch Anat Cytol Pathol; 1989; 37(1-2):21-8. PubMed ID: 2649019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular carcinoma.
    Franssila KO; Ackerman LV; Brown CL; Hedinger CE
    Semin Diagn Pathol; 1985 May; 2(2):101-22. PubMed ID: 3843689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
    Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
    Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.
    Roth LM; Miller AW; Talerman A
    Int J Gynecol Pathol; 2008 Oct; 27(4):496-506. PubMed ID: 18753973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary carcinoma of the thyroid. A discussion of its several morphologic expressions, with particular emphasis on the follicular variant.
    Rosaí J; Zampi G; Carcangiu ML
    Am J Surg Pathol; 1983 Dec; 7(8):809-17. PubMed ID: 6660353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate study of prognostic factors for differentiated thyroid carcinoma: the significance of histologic subtype.
    Noguchi M; Mizukami Y; Michigishi T; Koyasaki N; Ohta N; Miyazaki I
    Int Surg; 1993; 78(1):10-5. PubMed ID: 8473075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dense fibrosis. Another diagnostic criterion for papillary thyroid carcinoma.
    Isarangkul W
    Arch Pathol Lab Med; 1993 Jun; 117(6):645-6. PubMed ID: 8503738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differentiated thyroid cancer. Their peculiarities in typing and assessment of invasiveness].
    Kühne W; Willgeroth C
    Zentralbl Chir; 1990; 115(1):15-22. PubMed ID: 2180238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathology of papillary, follicular and Hürthle cell carcinomas of the thyroid.
    Soares P; Máximo V; Sobrinho-Simöes M
    Arkh Patol; 2003; 65(2):45-7. PubMed ID: 15357248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary carcinoma.
    Vickery AL; Carcangiu ML; Johannessen JV; Sobrinho-Simoes M
    Semin Diagn Pathol; 1985 May; 2(2):90-100. PubMed ID: 3843693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of well-differentiated thyroid carcinoma.
    Block MA
    Compr Ther; 1981 Dec; 7(12):52-8. PubMed ID: 7318406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma.
    Akslen LA; LiVolsi VA
    Cancer; 2000 Apr; 88(8):1902-8. PubMed ID: 10760768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
    Bhattacharyya N
    Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathological and clinical features of malignant thyroid tumors: classification, immunohistology, prognostic criteria].
    Schröder S
    Veroff Pathol; 1988; 130():1-159. PubMed ID: 3213226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.
    Wenig BM; Thompson LD; Adair CF; Shmookler B; Heffess CS
    Cancer; 1998 Feb; 82(4):740-53. PubMed ID: 9477108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
    Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
    Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.